Seidenberg Protzko Eye Associates participates in national clinical research studies.
The primary purpose of the studies we participate in is to determine and confirm the safety and effectiveness of new drugs, new combinations of drugs, new ways to use existing treatments, bio equivalency and devices for ocular diseases such as glaucoma, cataracts, dry eye, blepharitis, conjunctivitis and allergies. Participants are from within and outside our clinic patients and voluntarily agree to participate in our clinical trials.
Research studies are required by law to follow strict protocols to ensure the safety and health of each participant. An Independent Review Board (IRB) has approved any clinical trial we participate in. An informed consent document that details information about the trial and what should be expected is presented. The purpose of the study is fully explained and discussed with the patient. Any questions or concerns are addressed prior to any exams being completed.
Potential Benefits to participants
- Learn more about your condition
- May have access to new and/or more effective treatments not available outside the clinical-trial setting
- Receive study-related eye examinations at no cost (insurance is not required)
- Close monitoring, advice, and support by both the medical staff and the study team
- Receive financial compensation for participating in the clinical trial “Patient Stipend”
- The chance to play a role in improving the health of current and future generations
Please contact Carol, Senior Clinical Research Coordinator, for more information and to learn how to participate. 443-643-4506